Table 2.
Health-related quality of life at 6 months of follow-up
| EQ-5D Utilities | Month 0 | Month 1 | Month 6 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TM n (%) |
HM n (%) |
Total n (%) |
p | TM n (%) |
HM n (%) |
Total n (%) |
p | TM n (%) |
HM n (%) |
Total n (%) |
p | ||
| Mobility | No problems | 15 (60.0) | 12 (48.0) | 27 (54.0) | 0.29 | 16 (64.0) | 14 (58.3) | 30 (61.2) | 0.46 | 17 (68.0) | 16 (66.7) | 33 (67.3) | 0.58 |
| Some problems | 10 (40.0) | 13 (52.0) | 23 (46.0) | 9 (36.0) | 10 (41.7) | 19 (38.8) | 8 (32.0) | 8 (33.3) | 16 (32.7) | ||||
| Extreme problems | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0) | 0 (0.0) | ||||
| Self-care | No problems | 22 (88.0) | 22 (88.0) | 44 (88.0) | 0.67 | 23 (92.0) | 22 (91.7) | 45 (91.8) | 0.68 | 21 (84.0) | 23 (95.8) | 44 (89.8) | 0.19 |
| Some problems | 22 (88.0) | 22 (88.0) | 6 (12.0) | 2 (8.0) | 2 (8.3) | 4 (8.2) | 4 (16.0) | 1 (4.2) | 5 (10.2) | ||||
| Extreme problems | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | ||||
| Usual activities | No problems | 16 (64.0) | 14 (56.0) | 30 (60.0) | 0.84 | 13 (52.0) | 13 (54.2) | 26 (53.1) | 0.55 | 18 (72.0) | 12 (50.0) | 30 (61.2) | 0.22 |
| Some problems | 8 (32.0) | 10 (40.0) | 18 (36.0) | 12 (48.0) | 11 (45.8) | 23 (46.9) | 7 (28.0) | 11 (45.8) | 18 (36.7) | ||||
| Extreme problems | 1 (4.0) | 1 (4.0) | 2 (4.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (4.2) | 1 (2.0) | ||||
| Pain / discomfort | No problems | 11 (44.0) | 14 (56.0) | 25(50.0) | 0.08 | 13 (52.0) | 15 (62.5) | 28 (57.1) | 0.71 | 13 (52.0) | 12 (50.0) | 25 (51.0) | 0.87 |
| Some problems | 14 (56.0) | 8 (32.0) | 22 (44.0) | 10 (40.0) | 8 (33.3) | 18 (36.7) | 9 (36.0) | 10 (41.7) | 19 (38.8) | ||||
| Extreme problems | 0 (0.0) | 3 (12.0) | 3 (6.0) | 2 (8.0) | 1 (2.0) | 3 (6.1) | 3 (12.0) | 2 (8.3) | 5 (10.2) | ||||
| Anxiety / depression | No problems | 16 (64.0) | 16 (64.0) | 32 (64.0) | 0.62 | 18 (72.0) | 19 (79.2) | 37 (75.5) | 0.58 | 16 (64.0) | 19 (79.2) | 35 (71.4) | 0.50 |
| Some problems | 9 (36.0) | 9 (36.0) | 18 (36.0) | 6 (24.0) | 5 (20.8) | 11 (22.4) | 7 (28.0) | 4 (16.7) | 11 (22.4) | ||||
| Extreme problems | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (4.0) | 0 (0.0) | 1 (2.0) | 2 (8.0) | 1 (4.2) | 3 (6.1) | ||||
| TOTAL [95CI] | 0.81 [0.74;0.87] | 0.76 [0.64;0.88] | 0.78 [0.72;0.85] | 0.47 | 0.79 [0.70;0.88] | 0.83 [0.74;0.92] | 0.81 [0.75;0.87] | 0.49 | 0.82 [0.69;0.93] | 0.76 [0.65;0.87] | 0.79 [0.71;0.86] | 0.54 | |
| EQ-5D VAS | |||||||||||||
| TOTAL [95CI] | 64.00 [55.77;72.23] | 64.88 [51.69;74.07] | 64.83 [56.74;70.14] | 0.86 | 69.38 [60.82;76.38] | 66.96 [59.17;74.75] | 67.80 [62.49;73.10] | 0.71 | 72.71 [65.58;79.83] | 59.79 [49.44;70.14] | 66.74 [60.46;73.01] | 0.08 | |
TM tele-monitoring group, HM hospital monitoring group; N (month 0) = 50 (TM group: 25; HM group: 25). N (month 1) =49 (TM group: 25; HM group: 24). N (month 6) =49 (TM group: 25; HM group: 24). Values are expressed as means [95CI: 95% confidence interval of means]. EQ5D: EuroQoL-5D; VAS: Visual Analog Scale